Filing Details
- Accession Number:
- 0001493152-24-008804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 09:05:55
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 09:05:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1468929 | Nexgel Inc. | NXGL | Surgical & Medical Instruments & Apparatus (3841) | 264042544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1853617 | Mark Steven Glassman | C/O Nexgel, Inc. 2150 Cabot Blvd, West, Suite B Langhorne PA 19047 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-01 | 11,848 | $2.11 | 135,025 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2024-03-01 | 5,924 | $0.00 | 5,924 | $4.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,924 | 2024-03-01 | 2029-03-01 | No | 4 | A | Direct |
Footnotes
- The Reporting Person acquired the shares of common stock and warrant to purchase common stock reported on this Form 4 in connection with the Issuer's registered direct offering. The Reporting Person agreed not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of the shares of common stock and the shares of common stock underlying the warrant for a period of 180 days following March 1, 2024.